3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
14
Polycystic Ovary Syndrome
9
Neoplasms
5
Endometrial Neoplasms
3
Prostatic Neoplasms
2
Peripheral Nervous System Diseases
2
Obesity
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Leiomyoma
2
Insulin Resistance
2
Inflammation
2
Infertility, Female
2
Glioblastoma
2
Diabetes Mellitus
2
Colorectal Neoplasms
2
Cognitive Dysfunction
2
Cardiotoxicity
2
Weight Gain
1
Vomiting
1
Venous Thromboembolism
1
Vascular Malformations
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Stem Cell Transplant Complications
1
Interventions
Parathyroidectomy
5
lutetium Lu 177 dotatate
1
fluorocholine
1
acetaminophen, codeine drug combination
1
Tramadol
1
Tablets
1
Standard of Care
1
Sodium Chloride
1
Rubidium-82
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Denosumab
1
Dacarbazine
1
Control Groups
1
Congresses as Topic
1
Cinacalcet
1
Capsules
1
Bortezomib
1
Blood Specimen Collection
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Parathyroid Neoplasms
×
Tablets
×
Clear all
NCT03027557
2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3
Completed
46 enrolled
49 charts